Knut Borch-Johnsen

Author PubWeight™ 375.68‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes. Nat Genet 2008 35.06
2 New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet 2010 17.89
3 A variant in CDKAL1 influences insulin response and risk of type 2 diabetes. Nat Genet 2007 13.28
4 Many sequence variants affecting diversity of adult human height. Nat Genet 2008 12.80
5 Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type 2 diabetes. Nat Genet 2007 12.65
6 Genome-wide association yields new sequence variants at seven loci that associate with measures of obesity. Nat Genet 2008 12.43
7 SNPs in KCNQ1 are associated with susceptibility to type 2 diabetes in East Asian and European populations. Nat Genet 2008 8.63
8 European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur Heart J 2003 8.51
9 The same sequence variant on 9p21 associates with myocardial infarction, abdominal aortic aneurysm and intracranial aneurysm. Nat Genet 2008 6.72
10 Genetic variation in GIPR influences the glucose and insulin responses to an oral glucose challenge. Nat Genet 2010 6.66
11 European guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur J Cardiovasc Prev Rehabil 2007 6.10
12 European guidelines on cardiovascular disease prevention in clinical practice: executive summary: Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts). Eur Heart J 2007 5.92
13 Refining the impact of TCF7L2 gene variants on type 2 diabetes and adaptive evolution. Nat Genet 2007 5.88
14 A variant near MTNR1B is associated with increased fasting plasma glucose levels and type 2 diabetes risk. Nat Genet 2008 5.49
15 Genetic variant near IRS1 is associated with type 2 diabetes, insulin resistance and hyperinsulinemia. Nat Genet 2009 5.43
16 A randomized non-pharmacological intervention study for prevention of ischaemic heart disease: baseline results Inter99. Eur J Cardiovasc Prev Rehabil 2003 4.25
17 Low physical activity accentuates the effect of the FTO rs9939609 polymorphism on body fat accumulation. Diabetes 2007 4.19
18 Effect of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with type 2 diabetes detected by screening (ADDITION-Europe): a cluster-randomised trial. Lancet 2011 4.15
19 Age at initiation and frequency of screening to detect type 2 diabetes: a cost-effectiveness analysis. Lancet 2010 3.92
20 Albuminuria and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: the LIFE study. Ann Intern Med 2003 3.78
21 Very low levels of microalbuminuria are associated with increased risk of coronary heart disease and death independently of renal function, hypertension, and diabetes. Circulation 2004 3.71
22 Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women. Arch Intern Med 2004 3.68
23 Variations in the G6PC2/ABCB11 genomic region are associated with fasting glucose levels. J Clin Invest 2008 3.51
24 European guidelines on cardiovascular disease prevention in clinical practice: third joint task force of European and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of eight societies and by invited experts). Eur J Cardiovasc Prev Rehabil 2003 3.43
25 Common nonsynonymous variants in PCSK1 confer risk of obesity. Nat Genet 2008 3.24
26 Novel loci for adiponectin levels and their influence on type 2 diabetes and metabolic traits: a multi-ethnic meta-analysis of 45,891 individuals. PLoS Genet 2012 3.21
27 Prevalences of diabetes and impaired glucose regulation in a Danish population: the Inter99 study. Diabetes Care 2003 2.96
28 European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur J Cardiovasc Prev Rehabil 2007 2.70
29 Reduction in albuminuria translates to reduction in cardiovascular events in hypertensive patients: losartan intervention for endpoint reduction in hypertension study. Hypertension 2005 2.69
30 A Danish diabetes risk score for targeted screening: the Inter99 study. Diabetes Care 2004 2.65
31 The E23K variant of Kir6.2 associates with impaired post-OGTT serum insulin response and increased risk of type 2 diabetes. Diabetes 2003 2.41
32 Development of a type 2 diabetes risk model from a panel of serum biomarkers from the Inter99 cohort. Diabetes Care 2009 2.27
33 Moving to an A1C-based diagnosis of diabetes has a different impact on prevalence in different ethnic groups. Diabetes Care 2009 2.25
34 Age- and sex-specific prevalence of diabetes and impaired glucose regulation in 11 Asian cohorts. Diabetes Care 2003 2.18
35 Effect of losartan on sudden cardiac death in people with diabetes: data from the LIFE study. Lancet 2003 2.17
36 An education and training course in motivational interviewing influence: GPs' professional behaviour--ADDITION Denmark. Br J Gen Pract 2006 2.11
37 High-sensitivity C-reactive protein is only weakly related to cardiovascular damage after adjustment for traditional cardiovascular risk factors. J Hypertens 2006 2.03
38 Dietary glycemic index, glycemic load, fiber, simple sugars, and insulin resistance: the Inter99 study. Diabetes Care 2005 2.00
39 Frequency of the WHO metabolic syndrome in European cohorts, and an alternative definition of an insulin resistance syndrome. Diabetes Metab 2002 1.95
40 Glycemic thresholds for diabetes-specific retinopathy: implications for diagnostic criteria for diabetes. Diabetes Care 2010 1.95
41 The prevalence of the metabolic syndrome in a danish population of women with previous gestational diabetes mellitus is three-fold higher than in the general population. J Clin Endocrinol Metab 2005 1.80
42 A genome-wide association search for type 2 diabetes genes in African Americans. PLoS One 2012 1.72
43 Microalbuminuria in hypertensive patients with electrocardiographic left ventricular hypertrophy: the LIFE study. J Hypertens 2002 1.69
44 Risk scores for type 2 diabetes can be applied in some populations but not all. Diabetes Care 2006 1.68
45 The National Diabetes Register. Scand J Public Health 2011 1.65
46 The BIGTT test: a novel test for simultaneous measurement of pancreatic beta-cell function, insulin sensitivity, and glucose tolerance. Diabetes Care 2007 1.60
47 Representativeness in population-based studies: a detailed description of non-response in a Danish cohort study. Scand J Public Health 2006 1.59
48 All-cause mortality and pharmacological treatment intensity following a high risk screening program for diabetes. A 6.6 year follow-up of the ADDITION study, Denmark. Prim Care Diabetes 2012 1.59
49 A P387L variant in protein tyrosine phosphatase-1B (PTP-1B) is associated with type 2 diabetes and impaired serine phosphorylation of PTP-1B in vitro. Diabetes 2002 1.57
50 Association testing of novel type 2 diabetes risk alleles in the JAZF1, CDC123/CAMK1D, TSPAN8, THADA, ADAMTS9, and NOTCH2 loci with insulin release, insulin sensitivity, and obesity in a population-based sample of 4,516 glucose-tolerant middle-aged Danes. Diabetes 2008 1.55
51 Obesity and regional fat distribution in Kenyan populations: impact of ethnicity and urbanization. Ann Hum Biol 2008 1.53
52 Does albuminuria predict cardiovascular outcome on treatment with losartan versus atenolol in hypertension with left ventricular hypertrophy? A LIFE substudy. J Hypertens 2004 1.53
53 Risk of new-onset diabetes in the Losartan Intervention For Endpoint reduction in hypertension study. J Hypertens 2002 1.51
54 Natural history of insulin sensitivity and insulin secretion in the progression from normal glucose tolerance to impaired fasting glycemia and impaired glucose tolerance: the Inter99 study. Diabetes Care 2008 1.50
55 Studies of variations of the cyclin-dependent kinase inhibitor 1C and the cyclin-dependent kinase 4 genes in relation to type 2 diabetes mellitus and related quantitative traits. J Mol Med (Berl) 2005 1.45
56 Associations between features of glucose exposure and A1C: the A1C-Derived Average Glucose (ADAG) study. Diabetes 2010 1.45
57 Common type 2 diabetes risk gene variants associate with gestational diabetes. J Clin Endocrinol Metab 2008 1.43
58 [Screening and intervention. A strategy in type 2 diabetes?]. Ugeskr Laeger 2002 1.39
59 European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of eight societies and by invited experts). Atherosclerosis 2004 1.34
60 European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Atherosclerosis 2007 1.33
61 General practitioners trained in motivational interviewing can positively affect the attitude to behaviour change in people with type 2 diabetes. One year follow-up of an RCT, ADDITION Denmark. Scand J Prim Health Care 2009 1.33
62 N-terminal pro brain natriuretic peptide is inversely related to metabolic cardiovascular risk factors and the metabolic syndrome. Hypertension 2005 1.31
63 European guidelines on cardiovascular disease and prevention in clinical practice. Atherosclerosis 2003 1.31
64 Progression to impaired glucose regulation and diabetes in the population-based Inter99 study. Diabetes Care 2008 1.30
65 G-allele of intronic rs10830963 in MTNR1B confers increased risk of impaired fasting glycemia and type 2 diabetes through an impaired glucose-stimulated insulin release: studies involving 19,605 Europeans. Diabetes 2009 1.27
66 The functional Thr130Ile and Val255Met polymorphisms of the hepatocyte nuclear factor-4alpha (HNF4A): gene associations with type 2 diabetes or altered beta-cell function among Danes. J Clin Endocrinol Metab 2005 1.22
67 Frequency and risk factors of severe hypoglycemia in insulin-treated type 2 diabetes: a literature survey. J Diabetes Complications 2006 1.20
68 Validation of a multimarker model for assessing risk of type 2 diabetes from a five-year prospective study of 6784 Danish people (Inter99). J Diabetes Sci Technol 2009 1.20
69 Diabetes and impaired glucose tolerance among the inuit population of Greenland. Diabetes Care 2002 1.18
70 Commuting physical activity is favourably associated with biological risk factors for cardiovascular disease. Eur J Epidemiol 2007 1.18
71 Non-replication of genome-wide based associations between common variants in INSIG2 and PFKP and obesity in studies of 18,014 Danes. PLoS One 2008 1.17
72 Change in cardiovascular risk factors following early diagnosis of type 2 diabetes: a cohort analysis of a cluster-randomised trial. Br J Gen Pract 2014 1.17
73 Screen-detected diabetes, hypertension and hypercholesterolemia as predictors of cardiovascular mortality in five populations of Asian origin: the DECODA study. Eur J Cardiovasc Prev Rehabil 2006 1.16
74 High prevalence of markers of coronary heart disease among Greenland Inuit. Atherosclerosis 2007 1.15
75 Increased risk of childhood type 1 diabetes in children born after 1985. Diabetes Care 2002 1.14
76 High risk strategy in smoking cessation is feasible on a population-based level. The Inter99 study. Prev Med 2008 1.13
77 The KCNMB1 Glu65Lys polymorphism associates with reduced systolic and diastolic blood pressure in the Inter99 study of 5729 Danes. J Hypertens 2008 1.13
78 New diagnostic criteria for diabetes: is the change from glucose to HbA1c possible in all populations? J Clin Endocrinol Metab 2010 1.12
79 The type 2 diabetes associated minor allele of rs2237895 KCNQ1 associates with reduced insulin release following an oral glucose load. PLoS One 2009 1.11
80 Smoking cessation intervention in a large randomised population-based study. The Inter99 study. Prev Med 2005 1.10
81 It is possible to help smokers in early motivational stages to quit. The Inter99 study. Prev Med 2005 1.10
82 The association of alcohol and alcohol metabolizing gene variants with diabetes and coronary heart disease risk factors in a white population. PLoS One 2010 1.08
83 Analysis of separate and combined effects of common variation in KCNJ11 and PPARG on risk of type 2 diabetes. J Clin Endocrinol Metab 2005 1.05
84 Variants near MC4R are associated with obesity and influence obesity-related quantitative traits in a population of middle-aged people: studies of 14,940 Danes. Diabetes 2008 1.05
85 Comparisons of metabolic syndrome definitions in four populations of the Asia-Pacific region. Metab Syndr Relat Disord 2008 1.04
86 A -30G>A polymorphism of the beta-cell-specific glucokinase promoter associates with hyperglycemia in the general population of whites. Diabetes 2005 1.04
87 Effect of "motivational interviewing" on quality of care measures in screen detected type 2 diabetes patients: a one-year follow-up of an RCT, ADDITION Denmark. Scand J Prim Health Care 2011 1.03
88 Early childhood risk factors associated with type 1 diabetes--is gender important? Eur J Epidemiol 2005 1.03
89 General practitioners' adherence to guidelines on management of dyslipidaemia: ADDITION-Denmark. Scand J Prim Health Care 2010 1.03
90 Mutational analysis of the UCP2 core promoter and relationships of variants with obesity. Obes Res 2003 1.01
91 Identification of KCNJ15 as a susceptibility gene in Asian patients with type 2 diabetes mellitus. Am J Hum Genet 2010 1.01
92 Endocannabinoid receptor 1 gene variations increase risk for obesity and modulate body mass index in European populations. Hum Mol Genet 2008 1.00
93 Bimodal distribution of glucose is not universally useful for diagnosing diabetes. Diabetes Care 2008 1.00
94 Variation in the interleukin-6 receptor gene associates with type 2 diabetes in Danish whites. Diabetes 2004 0.99
95 Studies of the common DIO2 Thr92Ala polymorphism and metabolic phenotypes in 7342 Danish white subjects. J Clin Endocrinol Metab 2006 0.98
96 The functional Pro129Thr variant of the FAAH gene is not associated with various fat accumulation phenotypes in a population-based cohort of 5,801 whites. J Mol Med (Berl) 2007 0.98
97 The impact of a population-based multi-factorial lifestyle intervention on changes in long-term dietary habits: the Inter99 study. Prev Med 2008 0.97
98 Relationships between the functional PPARalpha Leu162Val polymorphism and obesity, type 2 diabetes, dyslipidaemia, and related quantitative traits in studies of 5799 middle-aged white people. Mol Genet Metab 2006 0.97
99 Association between dietary glycemic index, glycemic load, and body mass index in the Inter99 study: is underreporting a problem? Am J Clin Nutr 2006 0.97
100 HbA1c, fasting and 2 h plasma glucose in current, ex- and never-smokers: a meta-analysis. Diabetologia 2013 0.97
101 Urine albumin/creatinine ratio and echocardiographic left ventricular structure and function in hypertensive patients with electrocardiographic left ventricular hypertrophy: the LIFE study. Losartan Intervention for Endpoint Reduction. Am Heart J 2002 0.96
102 A randomized multifactorial intervention study for prevention of ischaemic heart disease (Inter99): the long-term effect on physical activity. Scand J Public Health 2008 0.96
103 Fat distribution and glucose intolerance among Greenland Inuit. Diabetes Care 2013 0.95
104 Evidence that the mitochondrial leucyl tRNA synthetase (LARS2) gene represents a novel type 2 diabetes susceptibility gene. Diabetes 2005 0.95
105 A multinational assessment of complications in type 1 diabetes: the DiaMond substudy of complications (DiaComp) level 1. Diab Vasc Dis Res 2006 0.95
106 Variants within the calpain-10 gene on chromosome 2q37 (NIDDM1) and relationships to type 2 diabetes, insulin resistance, and impaired acute insulin secretion among Scandinavian Caucasians. Diabetes 2002 0.94
107 Association between neuromedin U gene variants and overweight and obesity. J Clin Endocrinol Metab 2006 0.94
108 The metabolic syndrome identifies a heterogeneous group of metabolic component combinations in the Asia-Pacific region. Diabetes Res Clin Pract 2008 0.94
109 Variation in the gene encoding Krüppel-like factor 7 influences body fat: studies of 14 818 Danes. Eur J Endocrinol 2009 0.94
110 A randomized lifestyle intervention with 5-year follow-up in subjects with impaired glucose tolerance: pronounced short-term impact but long-term adherence problems. Scand J Public Health 2009 0.94
111 General effect on high-risk persons when general practitioners are trained in intensive treatment of type 2 diabetes. Scand J Prim Health Care 2008 0.93
112 Adherence to guidelines in people with screen-detected type 2 diabetes, ADDITION, Denmark. Scand J Prim Health Care 2009 0.93
113 AHSG tag single nucleotide polymorphisms associate with type 2 diabetes and dyslipidemia: studies of metabolic traits in 7,683 white Danish subjects. Diabetes 2008 0.93
114 Studies of the Gly482Ser polymorphism of the peroxisome proliferator-activated receptor gamma coactivator 1alpha (PGC-1alpha) gene in Danish subjects with the metabolic syndrome. Diabetes Res Clin Pract 2005 0.93
115 PGC-1alpha Gly482Ser polymorphism associates with hypertension among Danish whites. Hypertension 2005 0.93
116 The association between n-3 fatty acids in erythrocyte membranes and insulin resistance: the Inuit Health in Transition Study. Int J Circumpolar Health 2009 0.92
117 Diabetic retinopathy screening using digital non-mydriatic fundus photography and automated image analysis. Acta Ophthalmol Scand 2004 0.92
118 Screening for type 2 diabetes and population mortality over 10 years. Lancet 2013 0.92
119 Does albuminuria predict cardiovascular outcomes on treatment with losartan versus atenolol in patients with diabetes, hypertension, and left ventricular hypertrophy? The LIFE study. Diabetes Care 2006 0.92
120 Variation of the McKusick-Kaufman gene and studies of relationships with common forms of obesity. J Clin Endocrinol Metab 2004 0.92
121 The -250G>A promoter variant in hepatic lipase associates with elevated fasting serum high-density lipoprotein cholesterol modulated by interaction with physical activity in a study of 16,156 Danish subjects. J Clin Endocrinol Metab 2008 0.91
122 Association of variants in the sterol regulatory element-binding factor 1 (SREBF1) gene with type 2 diabetes, glycemia, and insulin resistance: a study of 15,734 Danish subjects. Diabetes 2008 0.91
123 Common variation in LMNA increases susceptibility to type 2 diabetes and associates with elevated fasting glycemia and estimates of body fat and height in the general population: studies of 7,495 Danish whites. Diabetes 2007 0.91
124 Screening for risk of cardiovascular disease is not associated with mental distress: the Inter99 study. Prev Med 2008 0.91
125 Prevalence of neuropathy and peripheral arterial disease and the impact of treatment in people with screen-detected type 2 diabetes: the ADDITION-Denmark study. Diabetes Care 2011 0.90
126 Is prevention of Type-2 diabetes feasible and efficient in primary care? A systematic PubMed review. Prim Care Diabetes 2006 0.89
127 Lipid-lowering drugs as primary prevention in general practice: do patients reach guideline goals and continue treatment? ADDITION Denmark. Scand J Prim Health Care 2011 0.88
128 Comment: studies of the Pro12Ala polymorphism of the PPAR-gamma gene in the Danish MONICA cohort: homozygosity of the Ala allele confers a decreased risk of the insulin resistance syndrome. J Clin Endocrinol Metab 2002 0.88
129 A statistical approach based on substitution of macronutrients provides additional information to models analyzing single dietary factors in relation to type 2 diabetes in danish adults: the Inter99 study. J Nutr 2005 0.88
130 Acceptance of the smoking cessation intervention in a large population-based study: the Inter99 study. Scand J Public Health 2005 0.88
131 Gender differences in the association between westernization and metabolic risk among Greenland Inuit. Eur J Epidemiol 2006 0.87
132 The impact of severe hypoglycemia and impaired awareness of hypoglycemia on relatives of patients with type 1 diabetes. Diabetes Care 2003 0.87
133 Comparison of accuracy of diabetes risk score and components of the metabolic syndrome in assessing risk of incident type 2 diabetes in Inter99 cohort. PLoS One 2011 0.87
134 Screening for diabetic retinopathy using a digital non-mydriatic camera compared with standard 35-mm stereo colour transparencies. Acta Ophthalmol Scand 2004 0.87
135 Lifestyle modifies obesity-associated risk of cardiovascular disease in a genetically homogeneous population. Am J Clin Nutr 2006 0.87
136 MTNR1B G24E variant associates With BMI and fasting plasma glucose in the general population in studies of 22,142 Europeans. Diabetes 2010 0.86
137 The socioeconomic correlates of global complication prevalence in type 1 diabetes (T1D): a multinational comparison. Diabetes Res Clin Pract 2005 0.86
138 Effect of intensive multifactorial treatment compared with routine care on aortic stiffness and central blood pressure among individuals with screen-detected type 2 diabetes: the ADDITION-Denmark study. Diabetes Care 2012 0.86
139 Variation in CAPN10 in relation to type 2 diabetes, obesity and quantitative metabolic traits: studies in 6018 whites. Mol Genet Metab 2006 0.85
140 Prevalence of age-related maculopathy and age-related macular degeneration among the inuit in Greenland. The Greenland Inuit Eye Study. Ophthalmology 2008 0.85
141 Genetic analysis of Kruppel-like zinc finger 11 variants in 5864 Danish individuals: potential effect on insulin resistance and modified signal transducer and activator of transcription-3 binding by promoter variant -1659G>C. J Clin Endocrinol Metab 2008 0.85
142 Albuminuria and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: the LIFE Study. Kidney Int Suppl 2004 0.85
143 Cardiovascular risk amongst migrant and non-migrant Greenland Inuit in a gender perspective. Scand J Public Health 2007 0.85
144 The metabolic syndrome--is one global definition possible? Diabet Med 2004 0.85
145 Effect of early intensive multifactorial therapy compared with routine care on self-reported health status, general well-being, diabetes-specific quality of life and treatment satisfaction in screen-detected type 2 diabetes mellitus patients (ADDITION-Europe): a cluster-randomised trial. Diabetologia 2013 0.84
146 Evidence of an association between the Arg72 allele of the peptide YY and increased risk of type 2 diabetes. Diabetes 2005 0.84
147 Genetic variation of the GLUT10 glucose transporter (SLC2A10) and relationships to type 2 diabetes and intermediary traits. Diabetes 2003 0.83
148 Register-based studies of diabetes. Scand J Public Health 2011 0.83
149 Comparison of different stepwise screening strategies for type 2 diabetes: Finding from Danish general practice, Addition-DK. Prim Care Diabetes 2010 0.82
150 HbA1c, fasting plasma glucose and the prediction of diabetes: Inter99, AusDiab and D.E.S.I.R. Diabetes Res Clin Pract 2011 0.82
151 Diabetes among Inuit migrants in Denmark. Int J Circumpolar Health 2005 0.82
152 The fasting plasma glucose cut-point predicting a diabetic 2-h OGTT glucose level depends on the phenotype. Diabetes Res Clin Pract 2002 0.82
153 Validation of a multi-marker model for the prediction of incident type 2 diabetes mellitus: combined results of the Inter99 and Botnia studies. Diab Vasc Dis Res 2011 0.82
154 European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force Of European and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of eight societies and by invited experts). Arch Mal Coeur Vaiss 2004 0.82
155 Smoking reduction intervention in a large population-based study. The Inter99 study. Prev Med 2005 0.82
156 Evidence for an association between the Leu162Val polymorphism of the PPARalpha gene and decreased fasting serum triglyceride levels in glucose tolerant subjects. Pharmacogenetics 2003 0.82
157 Prevention of type 2 diabetes: issues and strategies for identifying persons for interventions. Diabetes Technol Ther 2004 0.82
158 The prevalence and incidence of visual impairment in people of age 20-59 years in industrialized countries: a review. Ophthalmic Epidemiol 2003 0.81
159 A novel -192c/g mutation in the proximal P2 promoter of the hepatocyte nuclear factor-4 alpha gene (HNF4A) associates with late-onset diabetes. Diabetes 2006 0.81
160 Lack of association between PKLR rs3020781 and NOS1AP rs7538490 and type 2 diabetes, overweight, obesity and related metabolic phenotypes in a Danish large-scale study: case-control studies and analyses of quantitative traits. BMC Med Genet 2008 0.80
161 Transvascular low-density lipoprotein transport in patients with diabetes mellitus (type 2): a noninvasive in vivo isotope technique. Arterioscler Thromb Vasc Biol 2002 0.80
162 Microvascular retinopathy in subjects without diabetes: the Inter99 Eye Study. Acta Ophthalmol 2011 0.80
163 Identification and reproducibility of dietary patterns in a Danish cohort: the Inter99 study. Br J Nutr 2007 0.80
164 No consistent effect of ADRB2 haplotypes on obesity, hypertension and quantitative traits of body fatness and blood pressure among 6,514 adult Danes. PLoS One 2009 0.80
165 Combination of the electrocardiographic strain pattern and albuminuria for the prediction of new-onset heart failure in hypertensive patients: the LIFE study. Am J Hypertens 2008 0.80
166 Studies of CTNNBL1 and FDFT1 variants and measures of obesity: analyses of quantitative traits and case-control studies in 18,014 Danes. BMC Med Genet 2009 0.80
167 Predictions of type 2 diabetes and complications in Greenland in 2014. Int J Circumpolar Health 2006 0.79
168 A multinational comparison of complications assessment in type 1 diabetes: the DiaMond substudy of complications (DiaComp) level 2. Diabetes Care 2004 0.79
169 Variation in CHI3LI in relation to type 2 diabetes and related quantitative traits. PLoS One 2009 0.79
170 Psychological distress, cardiovascular complications and mortality among people with screen-detected type 2 diabetes: follow-up of the ADDITION-Denmark trial. Diabetologia 2014 0.79
171 Cumulative glycemia and microangiopathy in subjects with impaired glucose regulation in the Inter99 study. Diabetes Res Clin Pract 2010 0.79
172 A multinational assessment of complications in type 1 diabetes: the DiaMond substudy of complications (DiaComp) Level 1. Diab Vasc Dis Res 2006 0.78
173 The HADHSC gene encoding short-chain L-3-hydroxyacyl-CoA dehydrogenase (SCHAD) and type 2 diabetes susceptibility: the DAMAGE study. Diabetes 2006 0.78
174 Back to the future--do IGT and IFG have value as clinical entities? Diabetes Res Clin Pract 2008 0.78
175 Dietary patterns predict changes in two-hour post-oral glucose tolerance test plasma glucose concentrations in middle-aged adults. J Nutr 2009 0.78
176 [Microalbuminuria is associated with a fourfold increased risk of ischemic heart disease among hypertensive patients]. Ugeskr Laeger 2002 0.78
177 A common haplotype in the G-protein-coupled receptor gene GPR74 is associated with leanness and increased lipolysis. Am J Hum Genet 2007 0.78
178 Increased transvascular low density lipoprotein transport in insulin dependent diabetes: a mechanistic model for development of atherosclerosis. Atherosclerosis 2003 0.78
179 Variation in NCB5OR: studies of relationships to type 2 diabetes, maturity-onset diabetes of the young, and gestational diabetes mellitus. Diabetes 2004 0.77
180 A globally applicable screening model for detecting individuals with undiagnosed diabetes. Diabetes Res Clin Pract 2011 0.77
181 Family and population-based studies of variation within the ghrelin receptor locus in relation to measures of obesity. PLoS One 2010 0.77
182 Increased transvascular lipoprotein transport in diabetes: association with albuminuria and systolic hypertension. J Clin Endocrinol Metab 2005 0.77
183 Studies of association of the CASQ1 rs2275703 polymorphism in relation to type 2 diabetes and related quantitative metabolic traits among 7,088 Danish whites. Mol Genet Metab 2007 0.76
184 Dietary patterns, food and macronutrient intakes among adults in three ethnic groups in rural Kenya. Public Health Nutr 2011 0.76
185 [European practice guidelines on prevention of cardiovascular diseases: executive summary]. G Ital Cardiol (Rome) 2008 0.75
186 The effect of adding group-based counselling to individual lifestyle counselling on changes in dietary intake. The Inter99 study--a randomized controlled trial. Int J Behav Nutr Phys Act 2008 0.75
187 [Insulin pump treatment in Denmark]. Ugeskr Laeger 2004 0.75
188 Abdominal obesity has the highest impact on metabolic profile in an overweight African population. Ann Hum Biol 2012 0.75
189 [General practice plays a role in health check screening]. Ugeskr Laeger 2014 0.75
190 [The metabolic syndrome and exercise]. Ugeskr Laeger 2002 0.75
191 Comments to "The astonishing hypothesis" by Niels de Fine Olivarius (NdFO). Prim Care Diabetes 2012 0.75
192 [From evidence-based medicine to evidence-based organization]. Ugeskr Laeger 2010 0.75
193 Growth in the first year of life and the risk of type 1 diabetes in a Danish population. Paediatr Perinat Epidemiol 2007 0.75
194 [Multifactorial organization of diabetic care]. Ugeskr Laeger 2008 0.75
195 Model simulation of the patient flow through a screening centre for diabetic retinopathy. Acta Ophthalmol Scand 2005 0.75